ADMIN WARNING:
long con scammer, fake reviews https://xmrbazaar.com/forum/topic/51/post/1208/ 
N/A
(0 reviews)
- Domestic shipping - $20.00
- International shipping - $45.00
- Direct payment (XMR)
Foundayo 14.5MG 30 PILLS
Description
Foundayo (orforglipron) is an FDA-approved daily oral GLP-1 receptor agonist from Eli Lilly, launched in April 2026 for chronic weight management in adults with obesity or overweight. As a non-peptide small molecule, it works without food/water restrictions and showed up to 11.1% weight loss in 72-week trials.
Product image will be sent upon request as we do not share images on our post. They come in vials and we have lab test result from other clients.
Make sure you join the signal channel for update
Category: Health
Tags: Epitalon, weightloss, bodyfat
Trust rating: Caution
Published on: April 22, 2026
Views: 7
Legal Notice: Buyers and sellers are responsible for complying with all applicable laws in their jurisdictions. XmrBazaar does not verify legality and assumes no liability. Peer-to-peer cash-for-crypto trades are permitted if not conducted as a business and are compliant with local laws; otherwise, sellers must hold any required licenses or registrations. Listings involving fraud, violence, child exploitation, or other clearly illegal goods or services are strictly prohibited and will be removed once identified. Users are encouraged to report unlawful listings.
About the trader
Gamer for over 15 years traveled for tournaments won some too. Now i have a gaming shop with gaming cards, gift cards, rtx, ps,etc
I also have weight loss injections with lab test results available for proof. Check my product listing and i will make sure to add other peptide treatment which are not yet on my profile, but you can also message me demanding a specific treatment and treatment plans.
PLEASE JOIN MY SIGNAL GROUP CHAT ABOUT PETIDES AND RELATED TREATMENTS.
-----BEGIN PGP PUBLIC KEY BLOCK----- mDMEAAAAABYJKwYBBAHaRw8BAQdATLspVHIp8i6t051eVZEB2Ba6dl2XOodiL8wQ 6rooCmu0FGNoYW5jZUB4bXJiYXphYXIuY29tiJQEExYKADwWIQRd0PLgWMHzRqdd LH/KkJikOBSORwUCAAAAAAIbAwULCQgHAgMiAgEGFQoJCAsCBBYCAwECHgcCF4AA CgkQypCYpDgUjkdyegD/XHoCnEr4BFpPTYnpRTbRMeuytNpBk9qye3SKNy1c/SwA /27OpHUGKAwKGwZwpHSK2oqL8DYFNfaEzMT8q8O4f1QHuDgEAAAAABIKKwYBBAGX VQEFAQEHQOrHvfjz+ooGvFh/Pc0oAg6M3BeT3V8ul8CpCD/pyaIcAwEIB4h4BBgW CgAgFiEEXdDy4FjB80anXSx/ypCYpDgUjkcFAgAAAAACGwwACgkQypCYpDgUjkeL 7wD8CxU4O9fxgHjU/7WF0oL0i4fz/bYpKYUIBd7Pkpn8QQ0A/28F1+XNVSd5CLpA uN6DsqP35TivMF1iFH33BJ2DJmMH =ly8o -----END PGP PUBLIC KEY BLOCK-----